Yüklüyor......
Gemcitabine and Cisplatin induced posterior reversible encephalopathy syndrome: A case report with review of literature
Posterior reversible encephalopathy syndrome (PRES) is a recently described, scarcely documented clinical entity. PRES is caused by various factors, the most common being hypertension, followed by nonhypertensive causes such as renal diseases and immunosuppressive therapy. Recently, some cases have...
Kaydedildi:
| Yayımlandı: | J Res Pharm Pract |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Medknow Publications & Media Pvt Ltd
2016
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5084490/ https://ncbi.nlm.nih.gov/pubmed/27843969 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/2279-042X.192464 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|